Reversible Phase Transition for Durable Formamidinium-Dominated Perovskite Photovoltaics
© 2022 Wiley-VCH GmbH.
Veröffentlicht in: | Advanced materials (Deerfield Beach, Fla.). - 1998. - 34(2022), 39 vom: 02. Sept., Seite e2204458 |
---|---|
1. Verfasser: | |
Weitere Verfasser: | , , , , , , , , , , , |
Format: | Online-Aufsatz |
Sprache: | English |
Veröffentlicht: |
2022
|
Zugriff auf das übergeordnete Werk: | Advanced materials (Deerfield Beach, Fla.) |
Schlagworte: | Journal Article heat healing perovskite solar cells phase stability reversible phase transition |
Zusammenfassung: | © 2022 Wiley-VCH GmbH. Phase instability is one of the major obstacles to the wide application of formamidinium (FA)-dominated perovskite solar cells (PSCs). An in-depth investigation on relevant phase transitions is urgently needed to explore more effective phase-stabilization strategies. Herein, the reversible phase-transition process of FA1- x Csx PbI3 perovskite between photoactive phase (α phase) and non-photoactive phase (δ phase) under humidity, as well as the reversible healing of degraded devices, is monitored. Moreover, through in situ atomic force microscopy, the kinetic transition between α and δ phase is revealed to be the "nucleation-growth transition" process. Density functional theory calculation implies an enthalpy-driven α-to-δ degradation process during humidity aging and an entropy-driven δ-to-α healing process at high temperatures. The α phase of FA1- x Csx PbI3 can be stabilized at elevated temperature under high humidity due to the increased nucleation barrier, and the resulting non-encapsulated PSCs retain >90% of their initial efficiency after >1000 h at 60 °C and 60% relative humidity. This finding provides a deepened understanding on the phase-transition process of FA1- x Csx PbI3 from both thermodynamics and kinetics points of view, which also presents an effective means to stabilize the α phase of FA-dominated perovskites and devices for practical applications |
---|---|
Beschreibung: | Date Revised 28.09.2022 published: Print-Electronic Citation Status PubMed-not-MEDLINE |
ISSN: | 1521-4095 |
DOI: | 10.1002/adma.202204458 |